Department of Clinical Sciences Malmö, Clinical Obesity, Lund University Diabetes Center, Lund University, Sweden.
Department of Clinical Sciences Malmö, Clinical Obesity, Lund University Diabetes Center, Lund University, Sweden.
Diabetes Res Clin Pract. 2016 Mar;113:187-97. doi: 10.1016/j.diabres.2015.12.024. Epub 2016 Jan 15.
Weight loss improves insulin sensitivity and glucose tolerance in obese subjects with impaired glucose tolerance (IGT), but the long term dynamic effects on blood metabolites other than glucose during an oral glucose tolerance test (OGTT), are largely unknown. Here, we studied changes in OGTT-elicited metabolite patterns in obese subjects during a diet-induced weight loss study.
Blood samples from 14 obese individuals with IGT were collected at 0, 30 and 120 min during a standard 75 g OGTT at baseline (BMI 44 ± 2 kg/m(2)), after weight loss (BMI 36 ± 2 kg/m(2)) and after weight maintenance (BMI 35 ± 2 kg/m(2)). Serum metabolite levels were analyzed by gas chromatography/mass spectrometry and compared to a lean glucose tolerant group.
Changes in the OGTT-elicited metabolite patterns occurred differentially during weight loss and weight maintenance. Enhanced suppression of aromatic amino acids were associated with decreased insulinogenic index observed after weight loss (tyrosine: r=0.72, p=0.013; phenylalanine: r=0.63, p=0.039). The OGTT-elicited suppression and/or lack of increase in levels of glutamate, glutamine, isoleucine, leucine, and the fatty acids laurate, oleate and palmitate, improved towards the lean profile after weight maintenance, paralleling an improvement in glucose tolerance. The greater heterogeneity in the response before and after weight loss in the obese, compared to lean subjects, was markedly reduced after weight maintenance.
Diet-induced weight loss followed by weight maintenance results in changes in metabolite profiles associated with either hepatic insulin sensitivity or peripheral glucose tolerance. Our results highlight the importance of evaluating the effects of weight loss and weight maintenance separately.
在糖耐量受损(IGT)的肥胖人群中,体重减轻可改善胰岛素敏感性和葡萄糖耐量,但在口服葡萄糖耐量试验(OGTT)期间,除葡萄糖以外的血液代谢物的长期动态变化在很大程度上仍不清楚。在此,我们研究了在一项饮食诱导的减肥研究中,肥胖者在 OGTT 期间的代谢产物图谱的变化。
在基线时(BMI 44±2kg/m2)、减肥后(BMI 36±2kg/m2)和减肥维持后(BMI 35±2kg/m2),对 14 名患有 IGT 的肥胖个体进行了 75gOGTT 时的 0、30 和 120 分钟的血液样本采集。采用气相色谱/质谱法分析血清代谢物水平,并与瘦型糖耐量正常组进行比较。
在减肥和减肥维持期间,OGTT 诱导的代谢产物图谱的变化存在差异。芳香族氨基酸的抑制增强与减肥后胰岛素生成指数的降低有关(酪氨酸:r=0.72,p=0.013;苯丙氨酸:r=0.63,p=0.039)。OGTT 诱导的谷氨酸、谷氨酰胺、异亮氨酸、亮氨酸以及脂肪酸月桂酸、油酸和棕榈酸的抑制和/或缺乏增加,在减肥维持后向瘦型谱改善,与葡萄糖耐量改善相平行。与瘦型个体相比,肥胖个体在减肥前后的反应异质性更大,在减肥维持后明显降低。
饮食诱导的体重减轻后再维持体重,会导致与肝胰岛素敏感性或外周葡萄糖耐量相关的代谢产物图谱的变化。我们的研究结果强调了分别评估减肥和减肥维持效果的重要性。